Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience.
Ruggieri S, Ianniello A, Copetti M, Altieri M, Buscarinu MC, Centonze D, Cortese A, De Giglio L, Fantozzi R, Gasperini C, Grimaldi LME, Landi D, Marfia GA, Mirabella M, Nistri R, Nociti V, Oddo O, Romano S, Salemi G, Tortorella C, Pozzilli C, Petracca M. Ruggieri S, et al. Among authors: buscarinu mc. Neurotherapeutics. 2024 Apr;21(3):e00338. doi: 10.1016/j.neurot.2024.e00338. Epub 2024 Feb 26. Neurotherapeutics. 2024. PMID: 38413275 Free PMC article.
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey.
Altieri M, Capuano R, Bisecco A, d'Ambrosio A, Risi M, Cavalla P, Vercellino M, Annovazzi P, Zaffaroni M, De Stefano N, Stromillo ML, D'Amico E, Zanghì A, Buscarinu MC, Lanzillo R, De Luca G, Calabrese M, Lorefice L, Di Filippo M, Valentino P, Gajofatto A, Marfia GA, Fuiani A, Nociti V, Tedeschi G, Gallo A. Altieri M, et al. Among authors: buscarinu mc. Mult Scler Relat Disord. 2023 Sep;77:104870. doi: 10.1016/j.msard.2023.104870. Epub 2023 Jul 14. Mult Scler Relat Disord. 2023. PMID: 37454568 Free article.
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
Schiavetti I, Inglese M, Frau J, Signoriello E, Caleri F, Stromillo ML, Ferrò MT, Rilla MT, Gandoglia I, Gazzola P, Brichetto G, Pasquali L, Grimaldi L, Ulivelli M, Marinelli F, Cordera S, Clerico M, Conte A, Salvetti M, Battaglia MA, Franciotta D, Uccelli A, Sormani MP; CovaXiMS Study Group. Schiavetti I, et al. Eur J Neurol. 2023 Aug;30(8):2357-2364. doi: 10.1111/ene.15830. Epub 2023 May 28. Eur J Neurol. 2023. PMID: 37154406
Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.
Morena E, Romano C, Marconi M, Diamant S, Buscarinu MC, Bellucci G, Romano S, Scarabino D, Salvetti M, Ristori G. Morena E, et al. Among authors: buscarinu mc. Int J Mol Sci. 2023 Mar 23;24(7):6051. doi: 10.3390/ijms24076051. Int J Mol Sci. 2023. PMID: 37047023 Free PMC article. Review.
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.
Severa M, Rizzo F, Sinigaglia A, Ricci D, Etna MP, Cola G, Landi D, Buscarinu MC, Valdarchi C, Ristori G, Riccetti S, Piubelli C, Palmerini P, Rosato A, Gobbi F, Balducci S, Marfia GA, Salvetti M, Barzon L, Coccia EM. Severa M, et al. Among authors: buscarinu mc. Clin Transl Immunology. 2023 Mar 23;12(3):e1434. doi: 10.1002/cti2.1434. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36969367 Free PMC article.
Frailty and relapse activity in multiple sclerosis: A longitudinal observation.
Baione V, Canevelli M, Belvisi D, Buscarinu MC, Bellucci G, Fantozzi R, Nicoletti CG, Malatuni G, Cortese A, De Giglio L, Tartaglia M, Ferrazzano G, Malimpensa L, Leodori G, Bruno G, Ferraro E, Marfia GA, Centonze D, Salvetti M, Conte A. Baione V, et al. Among authors: buscarinu mc. Mult Scler Relat Disord. 2023 Apr;72:104603. doi: 10.1016/j.msard.2023.104603. Epub 2023 Mar 5. Mult Scler Relat Disord. 2023. PMID: 36905818
75 results